Analyst Ratings for Horizon Pharma PLC (HZNP)Updated: 2017-07-26
Analysts covering Horizon Pharma PLC (NASDAQ:HZNP) have given it a consensus rating of Buy. About 30 days ago, HZNP was issued an average rating of Buy.
11 analysts issued ratings on the stock, where 9 gave HZNP a buy rating, 0 issued an overweight rating, 2 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Today, there are 0 more analysts optimistic about the company future as compared with 90 days ago. Meanwhile, the number of analysts pessimistic about the company has increased by 0.
Investment analysts gave a few price targets for HZNP. The maximum price target given was 22, which equates to a potential upside of 66.41 percent. The most pessimistic price target was 10, implying a possible loss of -24.36 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.
Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. That number becomes -76.76 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -66.14 percent.
Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts made negative revisions. During this time, 0 analysts made positive revisions in their estimates for this fiscal year's earnings, while 0 analysts made negative revisions to their fiscal year's estimates.
In the trailing 52-weeks, HZNP hit 23.44 at the highest peak, while it's lowest trading point was 9.45. Currently the stock is 39.89 percent higher than its low, and below the high by 43.6 percent. HZNP has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The HZNP value stock report compares HZNP to some of its peers using value stock charts. The stock has a market capitalization of $2.19 billion. HZNP will post this quarters earnings in days, on 0000-00-00.